MedicineWatch US
Class II Recall

Wells Pharma of Houston LLC

Product
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
Reason
cGMP deviations.
Classification
Class II
Status
Ongoing
Lot
Lot 020226202150202, Exp Date 05/05/2026.
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Wells Pharma of Houston LLC — Class II Recall | MedicineWatch US